What Drugs Does Hospice Give at End of Life?

Hospice care at the end of life relies on a small set of medications chosen for comfort rather than cure, and the list is more focused than many families expect. Opioids such as morphine and hydromorphone sit at the center, addressing both pain and shortness of breath, while antipsychotics, benzodiazepines, anticholinergics, anti-nausea drugs, laxatives, and corticosteroids round out the toolkit. The specific drugs, doses, and combinations vary depending on the person’s symptoms, diagnosis, and ability to swallow, but the goal across the board is the same: keep the dying person as comfortable as possible without unnecessary interventions.

Opioids for Pain

Opioids are the backbone of hospice symptom management. Morphine, hydromorphone, and oxycodone are the most common choices, and when given at equivalent doses, none of these three is clearly more effective than another for moderate to severe cancer pain. The usual approach is to start a short-acting opioid at a low dose, available roughly every four hours as needed, then reassess and increase until the pain is controlled or side effects become limiting.¹

When a particular opioid stops working well or causes too many side effects, the hospice team may switch to a different one. This practice, called opioid rotation, takes advantage of the fact that individuals respond differently to different opioids. Someone who gets severe nausea from morphine, for instance, may tolerate hydromorphone much better. Conversion between opioids isn’t a simple one-to-one swap, and there is real variation among clinicians in how they calculate equivalent doses, which is one reason these changes are closely supervised.²

Fentanyl patches are another option, especially for people with stable pain who can no longer swallow pills. Fentanyl delivers a steady dose through the skin and avoids the need for oral medications entirely. It shows up frequently in hospice because of its convenience, though the onset is slow and it is harder to make quick dose adjustments compared to liquid morphine under the tongue.

One complication that hospice clinicians watch for is a paradoxical increase in pain sensitivity from opioids themselves. When repeated dose increases make pain worse rather than better, or a patient develops new widespread pain, the team may suspect this reaction and switch opioids or add other pain-relieving drugs to reduce the overall opioid load.³

Breathing Difficulties

Shortness of breath is one of the most distressing symptoms at end of life, both for the patient and for families watching. Opioids, again, are the first-line treatment. In someone who hasn’t been taking opioids before, even a small dose of oral morphine (around 5 mg or less) or a low parenteral dose often brings meaningful relief.⁴ For patients already on opioids for pain, the hospice team typically increases the existing dose by a percentage rather than adding a separate drug.

The mechanism here is worth understanding because it addresses a common fear. Opioids ease breathlessness primarily by reducing the brain’s sensitivity to rising carbon dioxide levels and slowing the respiratory drive just enough to relieve the panicky feeling of air hunger. A study of palliative care patients found that opioid treatment produced a significant improvement in the feeling of breathlessness, and the breathing rate dropped from a rapid average of about 42 breaths per minute to around 26, without causing dangerous respiratory depression.⁵ In other words, the drug calmed the breathing without stopping it. This is a crucial point for families who worry that the morphine is causing harm.

Terminal Agitation and Restlessness

In the final days or hours, some patients become visibly agitated, confused, or restless. This can look frightening: picking at bedsheets, moaning, trying to get out of bed, or appearing distressed in ways they can’t articulate. The medical term is terminal delirium or terminal agitation, and it affects a substantial share of dying patients.

Haloperidol, a low-dose antipsychotic, is the most widely used first-line medication for delirium at end of life. It is recommended across consensus-based guidelines, though high-quality evidence for its effectiveness is acknowledged to be limited.⁶ When haloperidol alone isn’t enough, adding a benzodiazepine like lorazepam can make a substantial difference. A randomized trial in patients with advanced cancer found that lorazepam combined with haloperidol produced nearly twice the reduction in agitation scores compared with haloperidol alone over eight hours. Patients in the combination group also needed fewer rescue doses of additional antipsychotics, and both nurses and family caregivers perceived the patients to be significantly more comfortable.⁷

Midazolam, another benzodiazepine, is considered one of the four essential drugs for quality care in dying patients. It acts quickly, has sedative and anti-anxiety properties, and can also control seizures, making it especially useful in the final hours when multiple symptoms may converge.⁸

Managing Airway Secretions

The noisy, gurgling breathing sometimes called a “death rattle” happens when a patient can no longer clear saliva and mucus from the airway. It usually occurs in the last day or two of life and is generally thought to be more distressing for the people in the room than for the patient, who is typically unconscious or semi-conscious. Anticholinergic drugs are the standard pharmaceutical approach. These medications reduce secretion production by blocking the nerve signals that stimulate mucous glands.

The evidence here is surprisingly mixed. A systematic review found no proof that any anticholinergic drug is superior to no treatment once the rattle has already started.⁹ However, a well-designed randomized trial showed that giving scopolamine butylbromide preventively, before the rattle begins, roughly cut the number of patients who developed it in half: about 13% of those who received the drug developed death rattle compared with 27% on placebo.¹⁰ The takeaway for families is that these drugs work better as prevention than as treatment, and repositioning the patient (turning them on their side, for instance) can help as much as or more than medication.

Nausea and Constipation

Nausea at end of life can come from the disease itself, from opioids, from a sluggish gut, or from multiple causes at once. The palliative care approach is to figure out which pathway is triggering the nausea and match the drug accordingly. Dopamine-blocking drugs like haloperidol or metoclopramide work for some causes, while antihistamines or anticholinergics are better suited for others.¹¹ Ondansetron, familiar to many people from chemotherapy, is sometimes used as well, though it’s not always the best first choice depending on the cause.

Constipation is almost universal in hospice patients on opioids, and managing it is treated as seriously as managing pain itself. A large survey of hospice organizations found that nearly 70% prescribed a bowel regimen to at least 90% of patients at admission, and over 84% had a formal protocol for opioid-induced constipation. The most commonly used laxatives were senna (a stimulant laxative), docusate (a stool softener), and the combination of both. Bisacodyl, polyethylene glycol, and lactulose were also frequently used.¹² Starting a laxative at the same time as starting an opioid is considered essential, not optional.¹³

Newer opioid-specific drugs like methylnaltrexone, which block opioid effects in the gut without reversing pain relief in the brain, are available but rarely used in hospice: over 75% of organizations in one survey said they never used them.¹² Cost and the effectiveness of simpler laxatives likely explain why these specialized agents remain uncommon.

Corticosteroids and Their Many Uses

Dexamethasone and other corticosteroids play a surprisingly versatile role in end-of-life care. It would be unusual for a patient with advanced cancer not to receive a corticosteroid at some point in their disease course.¹⁴ The indications range from specific problems like brain swelling and spinal cord compression to more general symptoms like poor appetite and fatigue.¹⁵

A trial of dexamethasone in patients with advanced cancer undergoing palliative care found that appetite improved significantly within three days and the improvement persisted through at least two weeks. Pain, anxiety, and overall well-being also showed measurable gains in the first few days.¹⁶ These drugs aren’t without downsides. Blood sugar spikes, insomnia, and mood changes can all occur, but in the context of someone with weeks or days to live, the short-term comfort benefits frequently outweigh those risks.

The Comfort Kit

Many hospice programs send a small box of emergency medications home with the patient, often called a comfort kit or emergency kit. The idea is practical: if a symptom flares at 2 a.m. and the patient can no longer swallow their regular pills, the family has what they need on hand while waiting for a nurse to arrive. A survey of hospice programs found that all kits contained medications for pain and breathlessness, about 81% included something for nausea and vomiting, and 76% contained a seizure medication. In more than 50% of cases, at least one medication from the kit ended up being used, and the vast majority of hospices reported that the kits often prevented unnecessary trips to the emergency department.¹⁷

One well-described comfort kit model includes morphine ampoules (for pain and breathlessness), haloperidol ampoules (for nausea or agitation), lorazepam tablets (for anxiety or seizures), atropine drops (for airway secretions), and acetaminophen suppositories (for fever or mild pain), all given either under the tongue or rectally. In practice, a majority of families who used the kit only needed one medication from it, and atropine drops were the single most commonly used item.¹⁸

Do Opioids Hasten Death?

This is the question that hangs heaviest for many families. When a loved one dies shortly after a dose increase, it’s natural to wonder whether the morphine played a role. The research is reassuring. A study of hospice patients found that while higher opioid doses were statistically associated with shorter survival, the relationship explained very little of the variation in how long patients lived. Complex disease factors were far more influential, and the authors concluded that concern about hastening death does not justify withholding opioid therapy.¹⁹

A separate study looking specifically at advanced cancer patients in hospice went further: after adjusting for clinical variables, there was no significant association between mortality and opioid dose at admission, dose at death, average dose, or day-by-day dosage changes. Even high doses had no measurable effect on survival.²⁰ The pattern that families observe, where the patient seems to decline just as doses go up, is almost always the disease progressing and the medication following the disease rather than the other way around.

When Swallowing Stops

One of the most anxiety-producing moments for families comes when their loved one can no longer swallow pills or liquids. This is common in the final days, and hospice teams prepare for it by having alternative routes ready.

• Sublingual: Liquid morphine or lorazepam tablets placed under the tongue, where they absorb through the mucous membranes. This is the simplest switch for most drugs.
• Rectal: Suppositories or liquid medication given rectally. Acetaminophen suppositories and some opioid formulations are commonly used this way.
• Subcutaneous: A small needle placed just under the skin, often connected to a continuous pump for morphine or hydromorphone. This is more common in inpatient hospice or when a visiting nurse can set it up.
• Transdermal: Fentanyl patches deliver steady opioid levels through the skin without any swallowing needed.
• Topical drops: Atropine eye drops placed under the tongue are a common workaround for secretions, since the same drug absorbs well through oral mucosa.

Comfort kits are deliberately designed with these non-oral routes in mind. Oral, sublingual, and rectal routes are the most common in home hospice, with some programs also including parenteral morphine for injection.¹⁷

Stopping Medications That No Longer Help

Just as important as the drugs hospice adds are the ones it takes away. Patients entering hospice often arrive on a long list of medications for chronic conditions, and many of those drugs no longer serve a useful purpose when comfort is the goal. Statins, diabetes medications, vitamins, blood pressure drugs, and osteoporosis treatments are common candidates for discontinuation.

The process doesn’t always happen as quickly as it should. One study found that statins had a median time to discontinuation of 93 days after hospice admission, and diabetes medications lingered even longer at a median of 197 days. Proton pump inhibitors (acid reflux drugs) were almost never stopped at all, with most patients staying on them for the entire hospice stay.²¹ Some of this slow tapering reflects legitimate caution (stopping a diabetes drug abruptly could cause dangerous blood sugar swings), but some simply reflects inertia. Fewer pills mean fewer side effects, lower costs, and less burden on caregivers who are already managing a difficult situation.

What Families Managing Medications at Home Should Know

In home hospice, family caregivers often become the ones actually giving the drugs, especially overnight and on weekends when nurses aren’t present. Research consistently shows that this responsibility causes significant anxiety. Caregivers report worrying about giving the correct dose at the correct time, about whether they’re using “as needed” medications too often or not enough, and above all, about accidentally shortening their loved one’s life.²²

These fears are understandable but largely misplaced, for the reasons covered earlier about opioid safety. Still, the practical challenges are real. Complex medication schedules, unfamiliar routes of administration, and the emotional weight of giving drugs to a dying family member add up. A survey of hospice providers found that about a third frequently encountered caregivers struggling with medication management. Only 42% of providers reported using any kind of proactive approach to assess whether caregivers were managing, and just 6% used teaching, simplification, and emotional support together as a strategy.²³

If you’re in this role, ask the hospice nurse to walk you through each medication physically: show you how to draw up a dose of liquid morphine, how to place a tablet under the tongue, or how to administer a suppository. Request a simple written schedule. And know that the hospice team expects you to call at any hour if you’re unsure. That is what they are there for.

Supply Shortages and Access Challenges

One problem that rarely gets discussed with families is that hospice programs themselves sometimes struggle to get the medications they need. A national survey found that 42% of hospices, and 61% of large ones, reported medication shortages. Among all agencies surveyed, 28% reported shortages of morphine and 20% reported shortages of hydromorphone.²⁴ These shortages are partly a downstream effect of tighter opioid regulations. Hospice pharmacies may face quota limits on how much they can order, and some local pharmacies decline to stock concentrated liquid morphine at all. When a shortage hits, the clinical team has to substitute a different opioid or formulation, which can introduce a temporary gap in symptom control.

Palliative Sedation for Refractory Symptoms

In a small number of cases, symptoms at the end of life prove resistant to every standard treatment. Pain, agitation, or breathlessness that persists despite aggressive medication management is called refractory, and for these patients, palliative sedation may be offered. This involves using sedative drugs to lower the patient’s level of consciousness enough that they are no longer aware of their suffering.

Midazolam is the most commonly used drug for palliative sedation, sometimes combined with other agents. In cases where midazolam fails, propofol, an anesthetic agent, has shown promise. A study of patients who did not achieve adequate sedation with standard drugs found that a protocol using low, incrementally increasing doses of propofol achieved excellent sedation levels without causing dangerous respiratory depression.²⁵ Palliative sedation is not euthanasia: the intent is to relieve suffering by reducing awareness, not to end life. The distinction matters legally and ethically, and hospice teams discuss it carefully with families before proceeding.

Children at End of Life

Pediatric hospice uses many of the same drug classes as adult hospice, but the specifics differ in important ways. Dosing, obviously, is weight-based and spans a much wider range. A review of pain management in dying children highlighted the impressive range of opioid dosages required across patients, reflecting the wide variability in how children metabolize these drugs.²⁶ A survey of pediatric palliative care across the Asia Pacific region found wide variation in preferred drugs for each symptom, driven not just by local drug availability but by genuine differences in clinical tradition and experience.²⁷

Formulation matters more with children. Liquid medications, dissolvable tablets, and transdermal patches are preferred over large pills for obvious reasons. Families of dying children face all the same medication-management challenges as adult caregivers, often with the added complexity of drugs that must be carefully measured by weight and adjusted more frequently as the child’s condition changes.

Non-Drug Approaches That Work Alongside Medications

Medications are the core of hospice symptom management, but they rarely work alone. Repositioning a patient can ease both breathlessness and secretion noises. Cool air from a fan directed toward the face can reduce the sensation of air hunger. Gentle massage, music therapy, and guided relaxation can lower anxiety and reduce the perceived intensity of pain. A review of non-drug therapies for chronic cancer pain concluded that these approaches have been significantly underused and should be considered alongside, or even before, standard drug regimens.²⁸ For families at the bedside, knowing they can do something physical, hold a hand, adjust a pillow, play familiar music, provides a sense of agency during a time that otherwise feels helpless.